Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Katia Zahaf"'
Autor:
Marius Ilié, Samantha Goffinet, Guylène Rignol, Virginie Lespinet-Fabre, Salomé Lalvée, Olivier Bordone, Katia Zahaf, Christelle Bonnetaud, Kevin Washetine, Sandra Lassalle, Elodie Long-Mira, Simon Heeke, Véronique Hofman, Paul Hofman
Publikováno v:
Cancers, Vol 16, Iss 12, p 2219 (2024)
The identification of ALK fusions in advanced non-small-cell lung carcinoma (aNSCLC) is mandatory for targeted therapy. The current diagnostic approach employs an algorithm using ALK immunohistochemistry (IHC) screening, followed by confirmation thro
Externí odkaz:
https://doaj.org/article/35081b0a7ec44789b7cf7bfb7deead80
Autor:
Arnaud Martel, Baharia Mograbi, Barnabe Romeo, Lauris Gastaud, Salome Lalvee, Katia Zahaf, Julien Fayada, Sacha Nahon-Esteve, Christelle Bonnetaud, Myriam Salah, Virginie Tanga, Stéphanie Baillif, Corine Bertolotto, Sandra Lassalle, Paul Hofman
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 13, p 11075 (2023)
Liquid biopsy and circulating tumor cell (CTC) screening has gained interest over the last two decades for detecting almost all solid malignancies. To date, the major limitation in terms of the applicability of CTC screening in daily clinical practic
Externí odkaz:
https://doaj.org/article/856a1654ebb142018947aeed147e35c2
Autor:
Arnaud Martel, Lauris Gastaud, Christelle Bonnetaud, Sacha Nahon-Esteve, Kevin Washetine, Olivier Bordone, Myriam Salah, Virginie Tanga, Julien Fayada, Virginie Lespinet, Maryline Allegra, Salome Lalvee, Katia Zahaf, Stephanie Baillif, Corine Bertolotto, Baharia Mograbi, Sandra Lassalle, Paul Hofman
Publikováno v:
Cancers, Vol 15, Iss 8, p 2372 (2023)
Ophthalmic malignancies include various rare neoplasms involving the conjunctiva, the uvea, or the periocular area. These tumors are characterized by their scarcity as well as their histological, and sometimes genetic, diversity. Uveal melanoma (UM)
Externí odkaz:
https://doaj.org/article/37658acfc3034122a792e85889ce764d
Autor:
Simon Heeke, Véronique Hofman, Jonathan Benzaquen, Josiane Otto, Virginie Tanga, Katia Zahaf, Maryline Allegra, Elodie Long-Mira, Sandra Lassalle, Charles-Hugo Marquette, Marius Ilie, Paul Hofman
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
The introduction of liquid biopsies for the detection of EGFR mutations in non-small cell lung cancer patients (NSCLC) has revolutionized the clinical care. However, liquid biopsies are technically challenging and require specifically trained personn
Externí odkaz:
https://doaj.org/article/a841eca024cf4bc39d51fb21134d4054
Autor:
Elodie Long-Mira, Alexandra Picard-Gauci, Sandra Lassalle, Véronique Hofman, Salomé Lalvée, Virginie Tanga, Katia Zahaf, Christelle Bonnetaud, Virginie Lespinet, Olivier Camuzard, Henri Montaudié, Gilles Poissonnet, Thierry Passeron, Marius Ilié, Paul Hofman
Publikováno v:
Diagnostics, Vol 12, Iss 3, p 751 (2022)
Testing for the BRAF mutation is mandatory for the management of patients with locally advanced or metastatic melanoma. Molecular analysis based on DNA sequencing remains the gold-standard method for the screening of the different BRAF mutations. The
Externí odkaz:
https://doaj.org/article/c45daa640a564eeda293675f6eb69b78
Autor:
Sandra Lassalle, Véronique Hofman, Simon Heeke, Jonathan Benzaquen, Elodie Long, Michel Poudenx, Elisabeth Lantéri, Jacques Boutros, Virginie Tanga, Katia Zahaf, Salomé Lalvée, Virginie Lespinet, Olivier Bordone, Jean-Marc Félix, Christelle Bonnetaud, Charles Marquette, Marius Ilie, Paul Hofman
Publikováno v:
Cancers, Vol 12, Iss 4, p 955 (2020)
Background: Assessment of actionable EGFR mutations is mandatory for treatment-naïve advanced or metastatic non-squamous lung carcinoma (NSLC), but the results need to be obtained in less than 10 working days. For rapid EGFR testing, an EGFR-specifi
Externí odkaz:
https://doaj.org/article/cce41d000a504ac5a9cd2aacafb33c04
Autor:
Simon Heeke, Jonathan Benzaquen, Elodie Long-Mira, Benoit Audelan, Virginie Lespinet, Olivier Bordone, Salomé Lalvée, Katia Zahaf, Michel Poudenx, Olivier Humbert, Henri Montaudié, Pierre-Michel Dugourd, Madleen Chassang, Thierry Passeron, Hervé Delingette, Charles-Hugo Marquette, Véronique Hofman, Albrecht Stenzinger, Marius Ilié, Paul Hofman
Publikováno v:
Cancers, Vol 11, Iss 9, p 1271 (2019)
Tumor mutational burden (TMB) has emerged as an important potential biomarker for prediction of response to immune-checkpoint inhibitors (ICIs), notably in non-small cell lung cancer (NSCLC). However, its in-house assessment in routine clinical pract
Externí odkaz:
https://doaj.org/article/44b397a93c0349328bac1c59198b2401
Autor:
Hofman, Arnaud Martel, Baharia Mograbi, Barnabe Romeo, Lauris Gastaud, Salome Lalvee, Katia Zahaf, Julien Fayada, Sacha Nahon-Esteve, Christelle Bonnetaud, Myriam Salah, Virginie Tanga, Stéphanie Baillif, Corine Bertolotto, Sandra Lassalle, Paul
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 13; Pages: 11075
Liquid biopsy and circulating tumor cell (CTC) screening has gained interest over the last two decades for detecting almost all solid malignancies. To date, the major limitation in terms of the applicability of CTC screening in daily clinical practic
Autor:
Marius Ilié, Véronique Hofman, Christophe Bontoux, Samantha Goffinet, Jonathan Benzaquen, Simon Heeke, Jacques Boutros, Sandra Lassalle, Elodie Long-Mira, Katia Zahaf, Salomé Lalvée, Virginie Lespinet-Fabre, Olivier Bordone, Virginie Tanga, Abel Gómez-Caro, Charlotte Cohen, Jean-Philippe Berthet, Charles-Hugo Marquette, Paul Hofman
Publikováno v:
Lung Cancer. 181:107230
Autor:
Elodie Long-Mira, Coraline Bence, H. Montaudié, Emmanuel Chamorey, Sandra Lassalle, Aleodor A. Andea, Marius Ilie, Katia Zahaf, Véronique Hofman, T. Passeron, Paul Hofman, A.F. Albertini, I. Liolios, J.-P. Lacour, A. Picard
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 34:984-994
Background Recent advances obtained with immune checkpoint inhibitors (ICIs) targeting the programmed cell death-1 (PD-1) protein have significantly improved the outcome of patients with metastatic melanoma. The PD-L1 expression in tumour cells as de